Lincoln Pharmaceuticals informs about closure of trading window

23 Sep 2024 Evaluate

Lincoln Pharmaceuticals has informed that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendment thereto (‘Regulations’) and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by the Company, the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2024 till 48 hours after the declaration of the Financial Results of the Company, for the quarter ended September 30, 2024. The date of meeting of the Board of Directors, to approve the Financial Results of the Company for the quarter ended September, 2024, will be informed in due course. Accordingly, all Directors, Senior Management Personnel, Promoter and Promoter Group of the Company and its subsidiaries including their Immediate Relatives and other Connected Persons are advised not to trade in securities of the Company during the aforesaid period of closure of trading window.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

617.50 -0.15 (-0.02%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.